Mostrar el registro sencillo del ítem
Effects of galanin n-terminal fragment (1-15) in the light/dark and tail suspension tests
dc.contributor.author | Flores-Burgess, Antonio | |
dc.contributor.author | Millón-Peñuela, Carmelo | |
dc.contributor.author | Narváez-Peláez, Manuel | |
dc.contributor.author | Santín-Núñez, Luis Javier | |
dc.contributor.author | Narváez-Bueno, José Ángel | |
dc.contributor.author | Díaz-Cabiale, Zaida | |
dc.date.accessioned | 2015-10-21T10:34:41Z | |
dc.date.available | 2015-10-21T10:34:41Z | |
dc.date.created | 2015 | |
dc.date.issued | 2015-10-21 | |
dc.identifier.uri | http://hdl.handle.net/10630/10554 | |
dc.description.abstract | Galanin N-terminal fragment (1-15) [Gal(1-15)] is involved in mood regulation. The intracerebroventricular (icv) administration of Gal(1-15) produces a depressive-like behaviour in the forced swim test (FST) and an anxiety-like behaviour in the open field test (OF) in rats. In this work we analyze the effect of Gal(1-15) in two more behavioural tests, the tail suspension test (TLT) and the light/dark test. Gal(1-15) (3nmol), effective dose in FST and OF, or artificial cerebrospinal were injected in animals (n=5-8) 15 minutes before the test. Behavioural assessment were conducted with at least one week between tests. Student’s t-test was used for comparision between experimental groups. In the light/dark test we analyzed during 5 min three parametres as indicators of anxiety-like behaviour. Gal(1-15) significantly reduced the time spent in the light compartiment by 52% (p<0.05) and the latency time for entering the dark box by 65% (p<0.05). An increased in the latency time for re-entering the light box was also observed (p<0.05). In the TST, total immobility time was analyzed during 6 min test as parameter indicator of depressive-like behaviour. Gal(1-15) significantly increased rat immobility by 16% (p<0.05). Our results describe that Gal(1-15) exerts strong depressive- and anxiety-like effects in these tests, indicating a potential role of Gal(1-15) in mood disorders. These results may give the basis for the development of novel therapeutic drugs targeting Gal(1-15) for depression and anxiety. | es_ES |
dc.description.sponsorship | Universidad de Málaga. Campus de Excelencia Internacional Andalucía Tech. Junta de Andalucia CVI6476 // Spanish Ministry of Economy and Competitiveness (PSI2013-44901-P to L.J.S). Author A.F-B. holds a ‘FPI’ grant from the Spanish Ministry of Economy and Competitiviness (grant number: BES-2014-068426). | es_ES |
dc.language.iso | eng | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | Neuropétidos | es_ES |
dc.subject.other | Gal(1-15) | es_ES |
dc.subject.other | Galanin | es_ES |
dc.subject.other | Anxiety | es_ES |
dc.subject.other | Depression | es_ES |
dc.title | Effects of galanin n-terminal fragment (1-15) in the light/dark and tail suspension tests | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.centro | Facultad de Medicina | es_ES |
dc.relation.eventtitle | Neuropeptide 2015 | es_ES |
dc.relation.eventplace | Aberden, Escocia | es_ES |
dc.relation.eventdate | 28-Septiembre-2015 | es_ES |
dc.identifier.orcid | http://orcid.org/0000-0003-4613-9430 | es_ES |
dc.rights.cc | by-nc-nd |